Category Archives: News
More Than Skin Deep: Beneath the Surface of a Routine Ampullary Adenoma
Posted in News
Comments Off on More Than Skin Deep: Beneath the Surface of a Routine Ampullary Adenoma
Diagnostic dilemma with synchronous upper and lower malignancy
Posted in News
Comments Off on Diagnostic dilemma with synchronous upper and lower malignancy
Fecal Mycobiota Combined with Host Immune Factors Distinguish Clostridioides difficile Infection from Asymptomatic Carriage
Although the role of gut microbiota in Clostridioides difficile infection (CDI) has been well established, little is known about the role of mycobiota in CDI. Here, we performed mycobiome data analysis in a well-characterized human cohort to evaluate t… Continue reading
Posted in News
Comments Off on Fecal Mycobiota Combined with Host Immune Factors Distinguish Clostridioides difficile Infection from Asymptomatic Carriage
Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
This study compared pharmacokinetics, symptomatic and endoscopic efficacy, safety, and immunogenicity of a subcutaneous formulation of the infliximab biosimilar CT-P13 (CT-P13 SC) versus intravenous CT-P13 (CT-P13 IV) in inflammatory bowel disease (IBD… Continue reading
Posted in News
Comments Off on Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
This study compared pharmacokinetics, symptomatic and endoscopic efficacy, safety, and immunogenicity of a subcutaneous formulation of the infliximab biosimilar CT-P13 (CT-P13 SC) versus intravenous CT-P13 (CT-P13 IV) in inflammatory bowel disease (IBD… Continue reading
Posted in News
Comments Off on Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
X chromosome contribution to the genetic architecture of primary biliary cholangitis
Genome-wide association studies (GWAS) in primary biliary cholangitis (PBC) have failed to find X chromosome (chrX) variants associated with the disease. Here, we specifically explore the chrX contribution to PBC, a sexually-dimorphic complex autoimmun… Continue reading
Posted in News
Comments Off on X chromosome contribution to the genetic architecture of primary biliary cholangitis
Commentary on the AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia
Posted in News
Comments Off on Commentary on the AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia
B lymphocytes contribute to celiac disease pathogenesis
Posted in News
Comments Off on B lymphocytes contribute to celiac disease pathogenesis
Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
A large unmet therapeutic need exists in inflammatory bowel diseases (IBD). Inhibition of interleukin (IL)-6 appears to be effective, but the therapeutic benefit of a complete IL-6/IL-6R blockade is limited by profound immunosuppression. Evidence has e… Continue reading
Posted in News
Comments Off on Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease
Impact of COVID-19 Pandemic on Gastrointestinal Procedures and Cancers in the United States. A Multicenter Research Network Study.
Posted in News
Comments Off on Impact of COVID-19 Pandemic on Gastrointestinal Procedures and Cancers in the United States. A Multicenter Research Network Study.